Table 3.
Comparison of MetS prevalence and associated components CPZ vs. CLZ groups.
| - | CPZ % (n) | CLZ % (n) | Exp(B) | P-value | 95%CI |
|---|---|---|---|---|---|
| WC (>=90cm) | 40%(40) | 32.7%(34) | 0.855 | 0.607 | 0.471-1.554 |
| Hyperglycemia | 36%(36) | 28.8%(30) | 0.727 | 0.294 | 0.4-1.319 |
| Hypertension (SBP) | 37%(37) | 46.2%(48) | 1.528 | 0.145 | 0.864-2.7 |
| Hypertension (DBP) | 10%(10) | 15.4%(16) | 1.459 | 0.388 | 0.619-3.441 |
| Hyperlipaemia (HDL-c) | 47%(47) | 70.2%(73) | 2.937 | <0.001* | 1.621-5.324 |
| Hyperlipaemia (TG) | 25%(25) | 25%(26) | 1.009 | 0.979 | 0.531-1.917 |
| MetS | 31%(31) | 37.5%(39) | 1.451 | 0.219 | 0.801-2.628 |